Navigation Links
ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
Date:2/5/2008

shown to be safe and well-tolerated.

About Oral Mucositis

Oral mucositis is a side effect experienced by cancer patients undergoing chemotherapy or radiation therapy. There are approximately 140,000 head and neck cancer patients in the European Union; patients receiving radiation therapy are at risk of developing oral mucositis. In addition to killing tumor cells, radiation therapy also adversely affects surrounding tissues including the inner lining (mucosa) of the mouth. The resulting "oral mucositis;" is the number one patient-reported debilitating side effect of cancer therapy. The condition is debilitating, resulting in ulcers, severe pain, dryness of the mouth, and inability to swallow. Oral mucositis often leads to breaks in antineoplastic therapy. Currently, there are no satisfactory methods for the treatment of oral mucositis in patients with solid tumors in the European Union.

About ActivBiotics

ActivBiotics is currently in the process of selling its proprietary assets, including M40403, through an Assignment for the Benefit of Creditors. The bidding for the assets, which may be purchased separately or in combination, will be conducted on March 14, 2008. Any person interested in purchasing the assets or learning more about the bidding process should contact Mr. Joseph F. Finn, Jr., CPA.

Bidding packages, which contain technical information and the terms of sale, have been assembled and are ready to be distributed subject to a potential purchaser entering into a standard form confidentiality agreement.

Request for Further Information

Interested parties can obtain a bidder's package by contacting Joseph F. Finn, Jr., CPA (jffinnjr@earthlink.net, phone 781-237-8840), Finn, Warnke & Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481-3613. For technical information or questions regarding the products, please contact Christo Shalish, cshalish@activbiotics
'/>"/>

SOURCE ActivBiotics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ewswire/ -- Warner Chilcott plc (Nasdaq: WCRX ) t...nced secondary offering of 20,000,000 of its ordin...share. The selling shareholders include funds aff...anking, J.P. Morgan Partners (advised by CCMP Capi...er institutional investors and members of the Comp...
(Date:11/19/2009)...wire/ -- In response to an ever-increasing number ...nes, Operation Pangea II, involving 24 countries, ...rganization,s International Medical Products Anti-... dangers of buying medicines online. ,, The wee...rrests and the seizure of thousands of potentially...
(Date:11/19/2009)... /PRNewswire-Asia/ -- ScinoPharm, a leading global...Is), announced that its,Tainan facility has receiv...afeBridge(R) Consultants, Inc. The Certification c... the safe handling of potent active,pharmaceutical...atories and,production areas used for the manufact...
Breaking Medicine Technology:Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4TriLink BioTechnologies Inc Relaunches Oligonucleotide Radiolabeling Services 14088 1TriLink BioTechnologies Inc Relaunches Oligonucleotide Radiolabeling Services 14088 2Better Day Care Smarter Kids 3F 57328 1Better Day Care Smarter Kids 3F 57328 2Better Day Care Smarter Kids 3F 57328 3Better Day Care Smarter Kids 3F 57328 4
... MELBOURNE, Australia, June 25, 2007 /PRNewswire-...ounced today positive results,from pre-clinical st...y formulated with retinoic acid, a leading topical...t used in,anti-aging cosmetics. , The proof of con...mount of retinoic acid delivered into the skin whe...
... CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - Pfizer a... Tablets 80 mg reduced the risk,of stroke, coronar...n type 2 diabetes patients who had no known corona...stroke or mini-stroke, compared,with placebo. The ...roke Prevention by Aggressive Reduction in Cholest...
Other Medicine Technology:Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 3
(Date:11/20/2009)...eurologist Closer to Understanding Brain Wiring an...SNewswire/ -- Dr. Jeremy Schmahmann, Professor of ...t at the Massachusetts General Hospital in Boston,...y,s research on the new field of study called "Con...n. ,, Dr. Schmahmann is an award-winning leader...
(Date:11/20/2009)..., Nov. 20 The American...ify health care reform legislation released this w...h insurance individual coverage mandate. The actua...e will minimize adverse selection stemming from mo...y the bill. ,, "The individual mandate language...
(Date:11/20/2009)...., Nov. 20 Following a recall by U...moved from sale Shedd,s Country Crock ® Side ...untry Crock ® Side Dishes DELUXE Four Cheese ..., The following code dates and UPCs are affected: ...LUXE Cheddar Broccoli Rice 21 oz, UPC 027400218316...
(Date:11/20/2009)...N.J., Nov. 20 Rates of i... peaked in late October, but the pandemic flu viru... all age groups, including the elderly, according ...(NYSE: DGX ), the world,s leading provider of di... In its most recent Quest Diagnostics Health Trend...
(Date:11/20/2009)..., Nov. 20 Centene Corp...l present at the Bank of America Merrill Lynch 200..., at the Crowne Plaza Hotel Times Square in New Yo...ember 2nd at 8:30 a.m. Eastern Time. Investors and... webcast of Centene,s presentation at: http://www...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...s to collaborate with The Bakersfield based Compre... new radiation therapy department. // In an oth...ation therapy machines to Ahmedabad Apollo Hospita...parate unit that will be operated by an outside gr...
... 'Southampton Remedi-Hand' has been developed by s...nd better than any currently available. // Th...er of complex movements and actions. The artificia...rs. Every year 200 people in the UK lose their ...
...feel that their neighborhoods are safe then their ...the study also points out that this does not mean ...ss overweight in comparison with their counterpart...of Pediatrics. Researchers had said that the...
... acid as found to reduce the rate of birth defects... Pediatrics have found that more than one third of...ce and pastas with folic acid.// Spina bifida and ...ancy. The defect causes paralysis in spina bifida ...
... room with cervical spinal injury may have more da...published in the Annals of Emergency Medicine, say...ries in patients over and above the normal X-rays....ct, more than a third of patients who were thought...
...arming announcement the Health Minister of West Be...t West Bengal was facing a Dengue epidemic and the...parison to last year.// Mishra also said tha...rted in N.Delhi last week in India. Dengue fever i...
Other Medicine News:Health News:New ultralight hand with better functionality and flexibility developed 2Health News:Safe Neighborhood Means Less TV For Preschool Children 2Health News:Folic acid enriched grain reduces birth defects 2
Streck-Detergent IIIA Balanced Electrolyte Solution
...d to establish the patient reportable range and es...c-Chex Linearity is available in five-vial sets wi... 3700 and 4000; Bayer ADVIA 120; Coulter STKS, MAX...500, R-1000, RAM-1, XE-2100 and XT-2000i. Open-via...
...sayed linearity control kits that are used to asse...nge of three- and five-part hematology instruments...the analyzer. CVA and CVA for CELL-DYN kits have c...odel and provide instrument-specific assay values ...
... red blood cell (nRBC) control for evaluating the ...5 hematology analyzer in its enumeration of the nR...H 750/LH 755. nRBC-Chex for LH is a two-level cont...C-Chex for LH has a 75-day closed-vial stability a...
Medicine Products: